All Posts By

Marcel Van de Vorst

HealthSage: €3M for AI Marcel van de VorstVenture Capital

HealthSage: €3M for AI

HealthSage AI secured €3M in Seed funding led by Peak.Capital to propel healthcare delivery with generative AI. Other investors included Healthy.Capital, Rubio Impact Ventures and several angel investors. The investment is earmarked to augment the team, commercialize solutions, and accelerate customer deployments. HealthSage AI pioneers transformative healthcare solutions, notably the Note-to-FHIR model, empowering healthcare professionals with generative AI tools to seamlessly integrate unstructured data into healthcare systems. We advised the company and its founders.
Marcel Van de Vorst
4 June 2024
Intrinsic ID acquired by Synopsys HomepageM&AMarcel van de VorstNiels HofkesSebastiaan WitkamTrack RecordVenture Capital

Intrinsic ID acquired by Synopsys

Synopsys, Inc. (Nasdaq: SNPS) has acquired Intrinsic ID, a leading provider of Physical Unclonable Function (PUF) IP used in the design of system-on-chips (SoCs). Intrinsic ID is a spin-out of Royal Philips Electronics. We advised the company and its selling shareholders including Prime Ventures and Robert Bosch Venture Capital.
Marcel Van de Vorst
10 April 2024
MoonPay Joins Forces with Onramper HomepageM&AMarcel van de VorstNiels HofkesTrack RecordVenture CapitalWouter Hofstee

MoonPay Joins Forces with Onramper

We advised Onramper on their strategic transaction with industry leader MoonPay which will democratize access to cryptocurrencies worldwide. Onramper is a leading fiat-to-crypto payments aggregator. The collaboration is set to offer MoonPay's clients a comprehensive solution to optimize conversion rates across various regions.
Marcel Van de Vorst
10 April 2024
Convious secures Series A funding extension LawyersMarcel van de VorstSebastiaan WitkamVenture Capital

Convious secures Series A funding extension

Attractions management platform innovator Convious has received an additional $9 million of Series A funding to support its next development phase. This has been secured by venture capital and private equity firm Wille Finance, with the participation of Orbit Capital, and existing investors. The extension of the round brings the total value of the Series A to $20 million, in combination of equity and debt. We advised Wille Finance.
Marcel Van de Vorst
10 April 2024
Yard Energy invests in Big Ass Battery LawyersMarcel van de VorstVenture Capital

Yard Energy invests in Big Ass Battery

YARD ENERGY has acquired a stake in Big Ass Battery, a Dutch high-tech scale-up that develops and builds energy storage systems. In addition, YARD ENERGY is providing growth financing. Big Ass Battery, based in Nuenen (NL), stands out for its innovative energy storage systems that are built entirely in-house. We advised YARD ENERGY, a venture capital investor in scale-ups playing a vital role in the energy transition.
Marcel Van de Vorst
21 April 2023
ETPA raises €5M by SET Ventures and ABN AMRO Marcel van de VorstVenture Capital

ETPA raises €5M by SET Ventures and ABN AMRO

Energy Trading Platform Amsterdam B.V. (ETPA) has been awarded a license to operate as a pan-European intraday energy exchange. By making energy trading faster and cheaper, ETPA’s intraday trading platform contributes to a flexible energy system that can absorb more energy from renewable sources. With the license, the company can expand its reach and offer services to energy traders across Europe. To support its international growth ambitions, ETPA raised € 5 million in growth financing from energy transition expert SET Ventures and sustainable finance leader ABN AMRO Sustainable Impact Fund. We advised ETPA on this transaction.
Marcel Van de Vorst
28 July 2022
Axion BioSystems acquires CytoSMART M&AMarcel van de VorstPrivate EquityVenture Capital

Axion BioSystems acquires CytoSMART

Axion BioSystems is a US-based life sciences tools company focused on advanced live-cell assay systems and a portfolio company of Summa Equity. Axion BioSystems has acquired CytoSMART, a Dutch biotechnology company focused on kinetic live-cell imaging analysis. The acquisition of CytoSMART puts Axion in a position for significant expansion in the fields of stem cell research, immuno-oncology, cell-based therapies, and drug discovery. We advised CytoSMART and its selling shareholders, including Holland Capital, BOM and ECFG (Eindhoven Corporate Finance Group), on this transaction.
Marcel Van de Vorst
28 July 2022
LeydenJar raises € 22 million in funding round LawyersMarcel van de VorstPrivate EquityTrack RecordVenture Capital

LeydenJar raises € 22 million in funding round

LeydenJar Technologies, a Dutch start-up originating from TNO that has developed battery technology based on 100% silicon anodes, has raised € 22 million in a new financing round for further development and upscaling. The capital was provided by a consortium of investors consisting of YARD ENERGY, Catalus Capital, Invest-NL, ING Sustainable Investments and Somerset Capital Partners together with a number of existing shareholders (including BOM, DOEN participaties and PVS Investments). We advised lead investor YARD ENERGY and the consortium of investors.
Marcel Van de Vorst
6 September 2021
PSG Makes Growth Investment in Visualfabriq HomepageLawyersM&AMarcel van de VorstPrivate EquityTrack RecordVenture Capital

PSG Makes Growth Investment in Visualfabriq

Visualfabriq has partnered with leading growth equity investment firm PSG. Visualfabriq’s SaaS platform supports global consumer packaged goods (CPG) manufacturers in managing and optimizing their promotions and demand planning. Its solutions are designed to improve revenue growth management for the world’s leading CPG brands by integrating big data, AI and intuitive workflows. PSG is a leading growth equity firm that focuses on partnering with mid-market software and technology-enabled services companies. PSG’s investment aims to accelerate Visualfabriq’s organic growth and assist in future product development. We advised Visualfabriq and its shareholders on this transaction.
Marcel Van de Vorst
17 August 2021